Auscann Group logo

AC8 - Auscann Group Share Price

A$0.18 0.0  0.0%

Last Trade - 5:10am

Sector
Healthcare
Size
Micro Cap
Market Cap £32.2m
Enterprise Value £21.3m
Revenue £219k
Position in Universe 1026th / 1851
Bullish
Bearish
Unlock AC8 Revenue
Momentum
Relative Strength (%)
1m -2.10%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -47.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.013 0.057 0.099 0.24 0.86 0.39 +98.6%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, AuscannGroup Holdings Ltd revenues decreased 55% to A$389K. Netloss decreased 7% to A$7.1M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Lower net loss reflectsOther Expenses decrease of 80% to A$480K (expense),Consulting fees other decrease of 72% to A$556K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AC8 Revenue Unlock AC8 Revenue

Net Income

AC8 Net Income Unlock AC8 Revenue

Normalised EPS

AC8 Normalised EPS Unlock AC8 Revenue

PE Ratio Range

AC8 PE Ratio Range Unlock AC8 Revenue

Dividend Yield Range

AC8 Dividend Yield Range Unlock AC8 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AC8 EPS Forecasts Unlock AC8 Revenue
Profile Summary

AusCann Group Holdings Ltd, formerly TW Holdings Limited, is an Australia-based company, which is engaged in the medical marijuana cultivation and distribution. The Company is in the process of researching and obtaining licenses for growing and distributions rights, as well as developing appropriate cultivation methods. The Company focuses on investigating other opportunities in the medical cannabis sector, including acquisition or investment in other international plant breeders, producers and suppliers.

Directors
Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated February 26, 1986
Public Since May 3, 1989
No. of Shareholders: n/a
No. of Employees: 27
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 317,047,357
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AC8 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AC8
Upcoming Events for AC8
Frequently Asked Questions for Auscann Group
What is the Auscann Group share price?

As of 5:10am, shares in Auscann Group are trading at A$0.18, giving the company a market capitalisation of £32.2m. This share price information is delayed by 15 minutes.

How has the Auscann Group share price performed this year?

Shares in Auscann Group are currently trading at A$0.18 and the price has moved by -40% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Auscann Group price has moved by -40.11% over the past year.

What are the analyst and broker recommendations for Auscann Group?

There are no analysts currently covering Auscann Group.

When will Auscann Group next release its financial results?

Auscann Group is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Auscann Group dividend yield?

Auscann Group does not currently pay a dividend.

Does Auscann Group pay a dividend?

Auscann Group does not currently pay a dividend.

When does Auscann Group next pay dividends?

Auscann Group does not currently pay a dividend.

How do I buy Auscann Group shares?

To buy shares in Auscann Group you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Auscann Group?

Shares in Auscann Group are currently trading at A$0.18, giving the company a market capitalisation of £32.2m.

Where are Auscann Group shares listed? Where are Auscann Group shares listed?

Here are the trading details for Auscann Group:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: AC8
What kind of share is Auscann Group?

Based on an overall assessment of its quality, value and momentum, Auscann Group is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Auscann Group share price forecast 2021?

We were not able to load any forecast data for Auscann Group.

How can I tell whether the Auscann Group share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Auscann Group. Over the past six months, the relative strength of its shares against the market has been 4.24%. At the current price of A$0.18, shares in Auscann Group are trading at 10.93% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Auscann Group PE Ratio?

We were not able to find PE ratio data for Auscann Group.

Who are the key directors of Auscann Group?

Auscann Group's management team is headed by:

Susan Hunter - SEC
Bruce McHarrie - DRC
Christopher Mews - NED
Robert Johnston - NEC
Krista Bates - NED
Nick Woolf - CEO
Who are the major shareholders of Auscann Group?

Here are the top five shareholders of Auscann Group based on the size of their shareholding:

Merchant Funds Management Pty Ltd Investment Advisor
Percentage owned: 13.43% (42.6m shares)
Darby (Elaine Lucy) Individual Investor
Percentage owned: 2.15% (6.82m shares)
Langman (Warren Sidney) Individual Investor
Percentage owned: 1.34% (4.24m shares)
Lu (Chien-Hsun George) Individual Investor
Percentage owned: 1.13% (3.59m shares)
Celtic Capital Pty. Ltd. Corporation
Percentage owned: 0.74% (2.35m shares)
Similar to AC8
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.